Avecia Biotechnology Mergers and Acquisitions Summary

Chemicals Company

Avecia Biotechnology has acquired 0 companies of its own. It has also divested 2 assets.

It’s largest disclosed sale occurred in 2004, when it sold NeoResins B.V. to Koninklijke DSM N.V. for $580M.

Join Mergr and gain access to Avecia Biotechnology’s M&A summary, the M&A summaries of companies just like it, as well as recent M&A activity in the chemicals sector.

M&A Summary

  • M&A Total Activity2
    • M&A Sell Activity2
  • M&A Buy/Sell Connections 2

Avecia Biotechnology, Inc.

155 Fortune Boulevard,
Milford, Massachusetts 01757
United States,
(508) 532-2500

Avecia is an international specialty chemicals manufacturer. At the time of the Cinven acquisition, it comprised multiple divisions. Five of those divisions, Stahl, Performance Intermediates, Neoresins, Fine Chemicals and Pharmaceuticals and Electronic materials have been sold to date. The remaining business is the Biotechnology division, encompassing the Biologics and DNA manufacturing activities.

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (0.0/yr) # - - - - - - 0
Sell (0.0/yr) # 2 - - - - - 2
vol $1.0B $1.0B

Most Recent M&A

Company Date Value Type
NeoResins B.V. 2004-12-14 580M EUR Divestiture
Waalwijk, Netherlands
Stahl Holdings BV 2001-12-19 423M EUR Divestiture
Waalwijk, Netherlands · www.stahl.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Chemicals - - 2 (100%) 1.0B (100%)
Total - - 2 $1.0B

By Geo

State/Country Buy Value Sell Value
Netherlands - - 2 1.0B
Total - - 2 $1.0B

Deal Values

sell # Total
$100M to $1B 2 $1.0B
Largest NeoResins B.V.
$580M (2004-12-14)

M&A Connections

Divested to
1 (50%)
1 (50%)

 Subscribe to unlock this and 159,618
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
  • 4.1K Private Equity Firms
  • 148K M&A Transactions
  • 156K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 47K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.